Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medios AGMEDOF 88 EV-to-OCF is 6.27 as of Aug. 11, 2026, which is 1% above its 10-year median of 6.23. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $76.88. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Medios AG ranks better than 54.24% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Medios AG's Enterprise Value is $446 Mil.
Medios AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $71 Mil. Therefore, Medios AG's EV-to-OCF for today is 6.27.
The historical rank and industry rank for Medios AG's EV-to-OCF or its related term are showing as below:
MEDOF'
s EV-to-OCF Range Over the Past 10 Years
Min: -163.39 Med: 6.23 Max: 85.83
Current: 6.4
During the past 13 years, the highest EV-to-OCF of Medios AG was 85.83. The lowest was -163.39. And the median was 6.23.
MEDOF's EV-to-OCF is ranked better than 54.24% of 118
companies
in the Medical Distribution industry
Industry Median: 7.475
vs MEDOF: 6.40
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medios AG's share price for today is $50.00.
Medios AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.648.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medios AG EV-to-OCF Related Terms
Medios AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Medios AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medios AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Medios AG's EV-to-OCF falls into.
Medios AG's current Enterprise Value is $446 Mil.
Medios AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medios AG (MEDOF) has a EV-to-OCF of 6.27 as of Aug. 11, 2026. This is near median its historical median of 6.23. According to the industry distribution chart, Medios AG ranks #54 out of 118 companies in the Medical Distribution industry, placing it in the top 45.8%.
Is Medios AG's EV-to-OCF too high?
Medios AG's current EV-to-OCF of 6.27 is near median its 10-year median of 6.23. The Medical Distribution industry median EV-to-OCF is 7.48. Medios AG's value of 6.27 is 16.1% below this industry median. Based on the distribution chart, Medios AG ranks #54 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medios AG ranks #54 out of 118 companies for EV-to-OCF. This puts Medios AG in the upper half of its industry. The industry median EV-to-OCF is 7.48. Medios AG's value of 6.27 is 16.1% below this benchmark. While the company's 10-year median is 6.23 vs. the industry median of 7.48, Medios AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 7.48, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current EV-to-OCF of 6.27 is 16.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current EV-to-OCF is 6.27, which is near median its own 10-year median of 6.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current EV-to-OCF of 6.27. The stock's GF Value™ is $76.88, compared to a current price of $50.00 — trading 35% below its estimated fair value. The current EV-to-OCF is 6.27, which is near median its 10-year median of 6.23 and 16.1% below the Medical Distribution industry median of 7.48. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Medios AG (MEDOF), the current EV-to-OCF is 6.27 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 35% below its estimated GF Value™ of $76.88.
Key valuation signals for MEDOF:
EV-to-OCF: 6.27 (near median its 10-year median of 6.23)
GF Value™: $76.88 vs. price of $50.00 (35% below fair value)
Industry Position: 16.1% below the Medical Distribution median (#54 of 118)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
